Shelf life (days): 1460.0
Formulation: A crystalline solid
Formal Name: methyl-d3 (S)-2-(2-chlorophenyl)-2-(6,7-dihydrothieno[3,2-c]pyridin-5(4H)-yl)acetate sulfate
Purity: ≥99% deuterated forms (d1-d3)
Formula Markup: C16H13ClD3NO2S / H2SO4
Formula Weight: 422.9
Notes: (S)-(+)-Clopidogrel-d3 is intended for use as an internal standard for the quantification of (S)-(+)-clopidogrel (Item No. 21002) by GC- or LC-MS. (S)-(+)-Clopidogrel is a prodrug form of the active metabolite of clopidogrel, which is a purinergic P2Y12 receptor antagonist.{69354} It inhibits aggregation of rat platelets induced by ADP, collagen, or thrombin ex vivo (ID50s = 4, 4.8, and 2.9 mg/kg, respectively). (S)-(+)-Clopidogrel increases tail bleeding time in rats in a dose-dependent manner. Formulations containing (S)-(+)-clopidogrel have been used in the treatment of acute coronary syndrome and peripheral artery disease and to reduce the reoccurrence of myocardial infarction and stroke.